6 research outputs found
ISSUES IN BIOTECHNOLOGY TEACHING - Teaching of Biotechnology in the Biochemistry Course
Biotechnology is taught in the Biochemistry course of the Faculty of Science of the Lisbon University during the last year of the course divide into two semesters. These two disciplines are optional with other disciplines that the students may choose in order to complete their knowledge in Biochemistry. Both disciplines have two credits, one for theory and the other for laboratory: Applied Biochemistry, comes in the first semester and Immobilized Biocatalysts in the second. Each discipline is taught during 13 weeks. The main goal of these two disciplines in the Biochemistry course is to give the students an applied vision, devoted to the industry, of the Biochemistry they have been taught during the previous three years
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
publishersversionpublishe
Effect of dietary palm oil on growth and carcass composition of Heterobranchus longifilis fingerlings
This study investigated the effects of dietary palm oil (PO) on growth performance and carcass composition of Heterobranchus longifilis with the goal of replacing dietary fish oil with palm oil. In this study triplicate groups of H. longifilis fingerlings were fed the experimental diets for 8 weeks. Five isonitrogenous (45% crude protein), isoenergetic (20 KJg-1) experimental diets were made containing either 6.0% FO and 0% PO, 4.5% FO and 1.5% PO; 3.0% FO and 3.0% PO; 1.5% FO and 4.5% PO; or 0% FO and 6.0% PO using soybean and fish meal as the protein source. Dietary palm oil had no significant effect on growth rate or feed conversion ratio. Similarly, No significant differences were observed between dietary treatments for moisture, protein and ash content in H. longifilis fingerlings. However, fillet saturated, monounsaturated fatty acids and liver lipid deposition were significantly (P0.05) higher in fish fed 6.0% PO diet. This study suggests that the replacement of cod liver oil by palm oil as lipid supplement in the diet permitted a clear improvement of growth and FCR of H. longifilis. This indicates that PO can effectively replace FO in the diet of the fish without compromising fish growth and feed efficiency
Metabolism of biodiesel-derived glycerol in probiotic Lactobacillus strains
Three probiotic Lactobacillus strains, Lactobacillus acidophilus, Lactobacillus plantarum, and Lactobacillus delbrueckii, were tested for their ability to assimilate and metabolize glycerol. Biodiesel-derived glycerol was used as the main carbon and energy source in batch microaerobic growth. Here, we show that the tested strains were able to assimilate glycerol, consuming between 38 and 48 % in approximately 24 h. L. acidophilus and L. delbrueckii showed a similar growth, higher than L. plantarum. The highest biomass reached was 2.11 gâLâ1 for L. acidophilus, with a cell mass yield (Y X/S) of 0.37 gâgâ1. L. delbrueckii and L. plantarum reached a biomass of 2.06 and 1.36 gâLâ1. All strains catabolize glycerol mainly through glycerol kinase (EC 2.7.1.30). For these lactobacillus species, kinetic parameters for glycerol kinase showed MichaelisâMenten constant (K m) ranging from 1.2 to 3.8 mM. The specific activities for glycerol kinase in these strains were in the range of 0.18 to 0.58 Uâmgâproteinâ1, with L. acidophilus ATCC 4356 showing the maximum specific activity after 24 h of cultivation. Glycerol dehydrogenase activity was also detected in all strains studied but only for the reduction of glyceraldehyde with NADPH (K m for DL-glyceraldehyde ranging from 12.8 to 32.3 mM). This enzyme shows a very low oxidative activity with glycerol and NADP+ and, most likely, under physiological conditions, the oxidative reaction does not occur, supporting the assumption that the main metabolic flux concerning glycerol metabolism is through the glycerol kinase pathway
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases known as synucleinopathies. The toxic properties of α-synuclein are conserved from yeast to man, but the precise underpinnings of the cellular pathologies associated are still elusive, complicating the development of effective therapeutic strategies. Combining molecular genetics with target-based approaches, we established that glycation, an unavoidable age-associated post-translational modification, enhanced α-synuclein toxicity in vitro and in vivo, in Drosophila and in mice. Glycation affected primarily the N-terminal region of α-synuclein, reducing membrane binding, impaired the clearance of α-synuclein, and promoted the accumulation of toxic oligomers that impaired neuronal synaptic transmission. Strikingly, using glycation inhibitors, we demonstrated that normal clearance of α-synuclein was re-established, aggregation was reduced, and motor phenotypes in Drosophila were alleviated. Altogether, our study demonstrates glycation constitutes a novel drug target that can be explored in synucleinopathies as well as in other neurodegenerative conditions.Authors were supported by: H.V.M. (FundacžaËo para a
CieËncia e Tecnologia (FCT), Portugal SFRH/BPD/64702/
2009 and SFRH/BPD/109347/2015; EU FP7 project
MEFOPA), L.M.A.O (FCT - SFRH/BD/23604/2005;
CIRM-BMFB joint grant, 315050 AZ0101-31P6855),
R.M.O. and T.S. (FCT SFRH/BPD/41416/2007; SFRH/
BPD/31209/2006); W.X. (Deutsche
Forschungsgemeinschaft, SFB539/A3); C.B. and F.G.
(Parkinsonâs UK and the Medical Research Council, UK).
S.E. is supported by Israel Academy of Sciences, Rappaport
Family Institute for Research in the Medical Sciences, The
Allen and Jewel Prince Center for Neurodegenerative
Disorders of the Brain. T.F.O. (EMBO Installation Grant;
Marie Curie IRG, Neurofold; DFG Center for Nanoscale
Microscopy and Molecular Physiology of the Brain; I.C.M.
(FCT SFRH/BPD/74287/2010; Investigador FCT IF/00772/
2013). This work was supported by: FCT PTDC/SAUNEU/
105215/2008, PTDC/QUI/73430/2006, PTDC/SAUENB/
117013/2010, PTDC/NEU-OSD/5644/2014; EU FP7
project MEFOPA; CIRM-BMFB joint grant (315050
AZ0101-31P6855); Max Planck Society; and European
Union (NEURASYNC PITNGA-2009-238316).info:eu-repo/semantics/publishedVersio